Ruud Ubink

Director In Vivo Pharmacology, Toxicology & DMPK at Byondis
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Arnhem-Nijmegen Region, NL
Skills

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 1 ratings
  • (1)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

Peter Vijn

Working with Ruud is rewarding in many respects. Above all it is a pleasure to work with him because he is such a nice and modest fellow. He is also a good teamplayer, a quick learner and a great generator of new ideas and initiatives. Ruud combines his ever present quest for best practice with efficient and on-time delivery of project needs, all together making him a great scientist and highly respected colleague!

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Experience

  • Byondis
    • Netherlands
    • Pharmaceutical Manufacturing
    • 200 - 300 Employee
    • Director In Vivo Pharmacology, Toxicology & DMPK
      • Apr 2020 - Present

  • Synthon
    • Netherlands
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Director In Vivo Pharmacology, Toxicology & DMPK
      • Nov 2019 - Apr 2020

    • Director DMPK
      • Jan 2017 - Nov 2019

    • Principal Scientist DMPK & PKPD
      • Aug 2011 - Dec 2016

  • Merck Sharp & Dohme
    • Senior Research Scientist
      • Nov 2009 - Aug 2011

      Pre-clinical DMPK work in the discovery phase of drug development. The main aim is understanding the ADME properties of a new drug and its relation to the observed activity, in order to predict the efficacy of a drug in humans. Pre-clinical DMPK work in the discovery phase of drug development. The main aim is understanding the ADME properties of a new drug and its relation to the observed activity, in order to predict the efficacy of a drug in humans.

  • Merck
    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Senior Research Scientist DMPK
      • Jan 2007 - Nov 2009

      Pre-clinical DMPK work in the discovery phase of drug development. The main aim is understanding the ADME properties of a new drug and its relation to the observed activity, in order to predict the efficacy of a drug in humans. Pre-clinical DMPK work in the discovery phase of drug development. The main aim is understanding the ADME properties of a new drug and its relation to the observed activity, in order to predict the efficacy of a drug in humans.

  • Organon
    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Senior Research Scientist Pharmacology
      • Jul 2002 - Dec 2006

      Group leader in the Department of Pharmacology, discovery work on androgens.

    • Research Scientist
      • Jan 2001 - Jun 2002

      Post doc in the Department of Pharmacology. Developing predictive models voor female contraception/ screening of new drugs (progestagens) in the discovery phase.

  • Karolinska Institutet
    • Sweden
    • Higher Education
    • 700 & Above Employee
    • Post doc
      • Aug 1998 - Dec 2000

      Post doc at the Department of Neuroscience, under guidance of Prof. T. Hökfelt. Histological, cellular and molecular research in the role of neuropeptide Y (NPY) in neurogenesis and axon guidance. Post doc at the Department of Neuroscience, under guidance of Prof. T. Hökfelt. Histological, cellular and molecular research in the role of neuropeptide Y (NPY) in neurogenesis and axon guidance.

Education

  • Radboud University
    PhD, Neuro-endocrinology
    1994 - 1998
  • Radboud University
    Drs, Biology
    1988 - 1993

Community

You need to have a working account to view this content. Click here to join now